Highlights and Quick Summary
- Net Debt/EBITDA for the quarter ending December 31, 2022 was 2.04 (a -85.44% decrease compared to previous quarter)
- Year-over-year quarterly Net Debt/EBITDA decreased by -130.99%
- Annual Net Debt/EBITDA for 2022 was 0.78 (a -171.73% decrease from previous year)
- Annual Net Debt/EBITDA for 2021 was -1.09 (a -25.12% decrease from previous year)
- Annual Net Debt/EBITDA for 2020 was -1.46 (a -45.47% decrease from previous year)
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Debt/EBITDA of Precigen, Inc.
Most recent Net Debt/EBITDAof PGEN including historical data for past 10 years.Interactive Chart of Net Debt/EBITDA of Precigen, Inc.
Precigen, Inc. Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 2.04 | 14.01 | -4.13 | -6.58 | 0.78 |
| 2021 | -3.61 | -4.47 | -3.21 | -6.06 | -1.09 |
| 2020 | -2.53 | -4.96 | 18.41 | -7.6 | -1.46 |
| 2019 | 2.83 | -3.79 | -3.01 | -0.79 | -2.68 |
| 2018 | 0.06 | 1.43 | 3.54 | 2.76 | 0.04 |
| 2017 | -2.41 | 2.77 | 4.29 | 9.22 | 1.1 |
| 2016 | 19.75 | 10.23 | -40.1 | 20.59 | 5.81 |
| 2015 | 7.41 | -7.54 | -22.22 | 0.86 | 1.18 |
| 2014 | 1.97 | -4.4 | -9.62 | 5.88 | 2.21 |
| 2013 | 8.68 | 5.22 | 6.34 | 0.0 | 2.9 |
| 2012 | 0.0 | 0.0 | – | – | 0.17 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology